Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yumi Kotoda
Institutions:
University of Yamanashi Hospital,
University of Yamanashi
Observed institutions:
Boston Children's Hospital,
Harvard University,
Kyoto Prefectural University of Medicine,
University of Yamanashi Hospital,
University of Yamanashi
ORCID:
0000-0003-4741-3163
Observed ORCID:
0000-0003-4741-3163
OpenAlex ID:
A5076602574
Vitreous metabolomics profiling of proliferative diabetic retinopathy
2020
·
Yohei Tomita
, Gael Cagnone
, et al.
·
Diabetologia
·
94
PDF
Müller glial responses compensate for degenerating photoreceptors in retinitis pigmentosa
2021
·
Yohei Tomita
, Chenxi Qiu
, et al.
·
Experimental & Molecular Medicine
·
57
PDF
An Ex Vivo Choroid Sprouting Assay of Ocular Microvascular Angiogenesis
2020
·
Yohei Tomita
, Zhuo Shao
, et al.
·
Journal of Visualized Experiments
·
22
Retinal glial remodeling by FGF21 preserves retinal function during photoreceptor degeneration
2021
·
Zhongjie Fu
, Chenxi Qiu
, et al.
·
iScience
·
21
PDF
Role of macrophage autophagy in postoperative pain and inflammation in mice
2023
·
Kazuha Mitsui
, Sohei Hishiyama
, et al.
·
Journal of Neuroinflammation
·
19
PDF
A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month Result
2023
·
Wataru Kikushima
, Yoichi Sakurada
, et al.
·
Pharmaceuticals
·
18
PDF
Comparison of one-year outcomes between as-needed brolucizumab and aflibercept for polypoidal choroidal vasculopathy
2023
·
Yoshiko Fukuda
, Yoichi Sakurada
, et al.
·
Japanese Journal of Ophthalmology
·
16
Characteristics of intermediate age-related macular degeneration with hyperreflective foci
2022
·
Wataru Kikushima
, Yoichi Sakurada
, et al.
·
Scientific Reports
·
16
PDF
Short-Term Outcomes of Three Consecutive Monthly Loading Administrations of Aflibercept 8 Mg for Treatment-Naïve Exudative Age-Related Macular Degeneration
2025
·
Shuhei Hosoda
, Yoichi Sakurada
, et al.
·
Pharmaceuticals
·
15
Recurrence of Intraocular Inflammation Following an Aflibercept 8-mg Injection in Eyes With a History of Intraocular Inflammation From Faricimab: A Case Report
2025
·
Shiori Sato
, Yoichi Sakurada
, et al.
·
Cureus
·
12
PDF
Association of Polyp Regression after Loading Phase with 12-Month Outcomes of Eyes with Polypoidal Choroidal Vasculopathy
2024
·
Misa Kimura
, Yoichi Sakurada
, et al.
·
Pharmaceuticals
·
12
PDF
INCIDENCE AND CHARACTERISTICS OF NEOVASCULAR AGE-RELATED MACULAR WITH OVER A 12-MONTH REMISSION AFTER THREE MONTHLY AFLIBERCEPT ADMINISTRATION: 60 Months Results of a Pro Re Nata Regimen
2024
·
Wataru Kikushima
, Yoichi Sakurada
, et al.
·
Retina
·
5
Genetic Factors Associated with Intraocular Inflammation After Brolucizumab Administration in Patients with Exudative Age-Related Macular Degeneration
2025
·
Seigo Yoneyama
, Yoichi Sakurada
, et al.
·
Genes
·
4
PDF
Brolucizumab versus aflibercept in treating exudative age-related macular degeneration: a 12-month pro re nata regimen
2026
·
Wataru Kikushima
, Yoichi Sakurada
, et al.
·
Scientific Reports
·
3
PDF
Comparison of Three Consecutive Monthly Administrations Between Aflibercept 8 mg and Brolucizumab 6 mg in Polypoidal Choroidal Vasculopathy
2025
·
Yoshiko Fukuda
, Yoichi Sakurada
, et al.
·
Pharmaceuticals
·
3
PDF
Genetic and Clinical Characteristics of Central Serous Chorioretinopathy With Steroid Use
2024
·
Seigo Yoneyama
, Ayumi Fukui
, et al.
·
Cureus
·
2
PDF
Left-Right and Upper–Lower Light Sensitivity Asymmetry in Visual Field Defects Caused by Pituitary Adenoma: A Retrospective Observational Study
2020
·
Yumi Kotoda
, Masakazu Kotoda
, et al.
·
Clinical ophthalmology
·
2
PDF
Temporal Dynamics of Polyp Regression and Retreatment Burden in As-Needed VEGF Inhibitor Therapy: A 24-Month Study
2026
·
Misa Kimura
, Yoichi Sakurada
, et al.
·
Pharmaceuticals
Genetic factors associated with response to as-needed brolucizumab treatment for exudative age-related macular degeneration
2026
·
Seigo Yoneyama
, Yoichi Sakurada
, et al.
·
Japanese Journal of Ophthalmology
Two year outcomes of as needed brolucizumab therapy in exudative age related macular degeneration with or without pachychoroid phenotype
2026
·
Yoshiko Fukuda
, Yoichi Sakurada
, et al.
·
Scientific Reports
PDF
A Novel Quaternary Ammonium N-Propylamiodarone Bromide Provides Long-Lasting Analgesia Against Corneal Pain
2024
·
Yumi Kotoda
, Sohei Hishiyama
, et al.
·
Drug Design Development and Therapy
Clinical and genetic characteristics of simple central serous chorioretinopathy according to age
2024
·
Taiyo Shijo
, Ayumi Fukui
, et al.
·
Ophthalmic Genetics
Show more works
View as search
Works count:
22
Citation count:
321
H-index:
11
I10-index:
11
Year
Topic
Type